Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
State Policy
New York Legislature Considers Mandatory Opioid CME
New legislation in New York would require healthcare professionals who prescribe pain medication to complete three hours…
Supreme Court Passes on Challenge to Alameda’s Drug Disposal…
The Supreme Court has declined to hear a challenge to Alameda County’s Drug Disposal Ordinance. The Court’s decision…
New York Introduces Pharmaceutical Cost Transparency Bill
New York is the latest state to introduce a “pharmaceutical cost transparency act,” following five others—California,…
Connecticut Delays Sunshine Reporting For APRNs Until 2017
Connecticut recently passed a law requiring manufacturers to report their transfers of value made to advance practice…
Massachusetts Introduces Drug Cost Transparency Bill That Would Cap Prices…
Massachusetts last week introduced a bill that calls for more transparency in the prices drug manufacturers charge for…
West Virginia Prescription Drug Advertising Expense Reporting Rule REPEALED
On March 24th, West Virginia’s Governor, Earl Ray Tomblin, approved SB 267, which repeals the state’s Prescription Drug…
Oregon Introduces Pharmaceutical Cost Transparency Bill; PhRMA and BIO…
On March 11, the Oregon House of Representatives introduced House Bill 3486, which would require pharmaceutical…
NLARx Dissolves–The National Legislative Association on Prescription…
The Board of Directors of the National Legislative Association on Prescription Drug Prices (NLARx) has voted to dissolve. The…
Physician Payments Sunshine Act: Vermont Gift Ban and Disclosure Law Update
In the last few months, Vermont’s Attorney General's Office has been busier than usual regarding its Prescribed Product…
Connecticut Transparency Law: Manufacturers Must Only Report Payments to…
Manufacturers must report quarterly on their transfers of value made to advance practice registered nurses (APRNs) practicing in…